Haoxi Health Technology Limited - Securities Purchase Agreement

Haoxi Health Technology Limited entered into a Securities Purchase Agreement with its CEO, Zhen Fan, to sell 40,000,000 Class B ordinary shares at $0.018 per share for a total of $720,000. The company intends to use the proceeds for working capital and general corporate purposes. This transaction is considered a related-party transaction and was approved by the audit committee. The shares were offered under exemptions from registration requirements. The transaction is expected to close on May 19, 2026. Following the closing, Zhen Fan will beneficially own approximately 83.83% of the company's voting power.